2014
DOI: 10.1002/stem.1602
|View full text |Cite
|
Sign up to set email alerts
|

Editorial: 2013—A Year of Clinical Success and Great Scientific Innovation in the Stem Cell Field

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
7
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(8 citation statements)
references
References 18 publications
1
7
0
Order By: Relevance
“…01; N = 6) ( Fig 3B ). These observations are consistent with our previous report showing that in cultured neuron stem cells, morphine decreases the percentage of immature neurons such as beta-tubulin 3(TUJ-1) positive cells in neural stem cell cultures, but it increases the percentage of GFAP-expressing glia [ 24 ].…”
Section: Resultssupporting
confidence: 93%
See 2 more Smart Citations
“…01; N = 6) ( Fig 3B ). These observations are consistent with our previous report showing that in cultured neuron stem cells, morphine decreases the percentage of immature neurons such as beta-tubulin 3(TUJ-1) positive cells in neural stem cell cultures, but it increases the percentage of GFAP-expressing glia [ 24 ].…”
Section: Resultssupporting
confidence: 93%
“…An alternative explanation for the negative effect on adult neurogenesis is that morphine alters the fate of early progenitors indirectly, inducing more neural stem cell differentiation into glia rather than neurons. Our recent in vitro study with the isolated progenitor cells from the mouse hippocampus indicates that morphine alters the lineage of the progenitors during differentiation by regulating the Prox1/Notch1 pathway via the drug’s control of miR-181a [ 24 ]. Similar results were observed with our current in vivo study.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Coculture of HSCs with M2‐AKT cells resulted in the expansion of phenotypically defined HSCs, but these expanded HSCs were dysfunctional as assessed by both, in vitro and in vivo assays. MSCs are being used in regenerative medicine for various hematological and nonhematological conditions . Our data suggest that it may be important to examine whether the signaling mechanisms prevailing in these cells affect the outcome of the therapy.…”
Section: Discussionmentioning
confidence: 95%
“…YB-1 is overexpressed in breast cancer, especially in the aggressive triple-negative (TNBC) subtypes, almost 70% of which are strongly positive for YB-1 [ 10 ]. Davies and coworkers [ 14 ] elegantly showed that YB-1 contributes to the conversion of hormone receptor-positive breast cancer cells to the TNBC phenotype.…”
Section: Introductionmentioning
confidence: 99%